ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.772,85
0,50%
S&P 500
5.222,68
0,16%
Dow Jones
39.512,84
0,32%
Euro vs US Dollar
1,07875
-0,01%
Bitcoin
60.958,65
0,26%
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Nemaura Medical Inc (NMRD)

  7. Nemaura Medical Inc (NMRD) News

NMRD

Nemaura Medical (NMRD)

Nemaura Medical Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:NMRD
DatumZeitQuelleÜberschriftSymbolFirma
19/04/202422h05Edgar (US Regulatory)Form PRE 14C - Other preliminary information statementsNASDAQ:NMRDNemaura Medical Inc
10/04/202422h16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NMRDNemaura Medical Inc
26/02/202422h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NMRDNemaura Medical Inc
22/01/202422h15GlobeNewswire Inc.Maxim Group LLC to Host the 2024 Healthcare IT Virtual Conference on Wednesday, January 24th & Thursday, January 25th at 9:00 A.M. ETNASDAQ:NMRDNemaura Medical Inc
17/01/202423h17Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:NMRDNemaura Medical Inc
17/01/202423h15Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:NMRDNemaura Medical Inc
09/01/202423h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NMRDNemaura Medical Inc
09/01/202423h29Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:NMRDNemaura Medical Inc
03/01/202422h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NMRDNemaura Medical Inc
03/01/202413h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NMRDNemaura Medical Inc
03/01/202413h00GlobeNewswire Inc.Important Update on Listing Status and Strategic DirectionNASDAQ:NMRDNemaura Medical Inc
13/12/202314h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NMRDNemaura Medical Inc
13/12/202314h00GlobeNewswire Inc.Nemaura Medical Inc. Receives Positive Nasdaq Listing DecisionNASDAQ:NMRDNemaura Medical Inc
07/12/202316h46Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:NMRDNemaura Medical Inc
21/11/202314h38Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NMRDNemaura Medical Inc
21/11/202314h30GlobeNewswire Inc.Nemaura Medical Inc. Secures $10 Million Non-Dilutive Credit Facility to Fuel Strategic GrowthNASDAQ:NMRDNemaura Medical Inc
14/11/202314h00GlobeNewswire Inc.Nemaura Launches Direct to Consumer Offering of Metabolic Health Program in Combination with GLP-1 Weight Loss DrugsNASDAQ:NMRDNemaura Medical Inc
13/11/202322h30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NMRDNemaura Medical Inc
13/11/202322h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NMRDNemaura Medical Inc
13/11/202322h14GlobeNewswire Inc.Nemaura Medical Reports Fiscal Second Quarter 2024 Results and Provides Business UpdateNASDAQ:NMRDNemaura Medical Inc
12/10/202322h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NMRDNemaura Medical Inc
06/10/202322h10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NMRDNemaura Medical Inc
26/09/202315h50GlobeNewswire Inc.Nemaura Medical Announces Appointment of Mr Nikolai Rozanov as Strategic Adviser in Artificial Intelligence, to Assist in Development of its AI Health Coach, and Strengthen Outcomes in its CGM Based Metabolic and Type 2 Diabetes Programs.NASDAQ:NMRDNemaura Medical Inc
22/09/202321h05GlobeNewswire Inc.Maxim Group LLC to Host the Virtual Tech Conference Series: Emerging Growth in A.I., on Tuesday, September 26th & Wednesday, September 27th at 8:00 A.M. ET.NASDAQ:NMRDNemaura Medical Inc
18/09/202315h15GlobeNewswire Inc.Nemaura Medical to Present at the Maxim Group Emerging Growth in A.I. ConferenceNASDAQ:NMRDNemaura Medical Inc
14/09/202314h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NMRDNemaura Medical Inc
14/09/202314h00GlobeNewswire Inc.Nemaura Medical Provides Update on Nasdaq Compliance Status and ProcessNASDAQ:NMRDNemaura Medical Inc
13/09/202314h03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NMRDNemaura Medical Inc
13/09/202314h00GlobeNewswire Inc.Nemaura Medical Announces Interim Results from its Collaboration with the UK’s National Health Service on its Metabolic Health & Weight Loss ProgramNASDAQ:NMRDNemaura Medical Inc
12/09/202315h26GlobeNewswire Inc.Nemaura Medical Announces Participation at HLTH 2023, Las VegasNASDAQ:NMRDNemaura Medical Inc
 Showing the most relevant articles for your search:NASDAQ:NMRD

Kürzlich von Ihnen besucht

NASDAQ
MSBK
Main Street Banks
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten